Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Maternal Hypoxemia and oxidative stress in the fetus, newborn, and adult. exercise training for peripheral artery disease (Study ST000872)

Reversed phase NEGATIVE ION MODE (Analysis AN001404)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14	F15
9(10)-EpO	ME225472	3.22	0.20	0.24	1.10	0.30	0.37	0.31	8.42	0.30	0.14	0.16	0.13	0.23	0.19	0.16
9(10)-EpOME	ME225474	3.73	0.50	0.54	0.50	1.48	0.63	1.74	6.11	0.71	0.05	0.08	0.06	0.06	0.10	0.11
12(13)-EpOME	ME225473	2.86	1.30	0.84	0.64	1.50	1.64	1.02	4.04	1.24	0.04	0.07	0.04	0.04	0.14	0.15
SUM-TriHOME	ME225442	2.86	0.67	0.68	1.37	0.46	1.09	0.59	3.43	0.56	0.34	0.38	0.38	0.50	0.52	0.64
14_15-DiHETE	ME225454	0.25	0.26	5.01	2.87	0.79	0.16	8.58	0.63	0.79	0.08	0.06	0.28	0.09	0.09	0.27
17_18-DiHETE	ME225453	0.17	0.24	5.10	3.39	0.66	0.27	7.22	0.79	0.71	0.09	0.11	0.36	0.43	0.07	0.33
12-HEPE	ME225466	0.09	0.05	0.14	7.80	0.21	0.05	0.53	0.52	0.08	0.04	0.01	0.29	0.82	0.05	0.54
14-HDoHE	ME225470	0.13	0.27	0.59	6.45	0.13	0.22	1.03	0.25	0.60	0.07	0.04	0.33	0.58	0.14	0.20
12-HETE	ME225461	0.27	0.16	0.12	5.24	0.67	0.19	0.39	1.72	0.19	0.27	0.09	0.67	2.31	0.54	0.45
TXB2	ME225436	0.26	0.29	0.79	3.67	0.28	0.18	0.27	0.44	0.32	0.88	0.40	1.16	2.46	1.40	0.53
PGE2	ME225438	0.13	0.26	0.18	0.27	1.17	1.23	0.83	1.25	1.28	0.74	5.13	0.55	1.23	0.24	0.03
PGF2a	ME225440	0.29	0.44	0.57	0.33	0.48	0.90	0.52	1.05	0.72	1.20	2.32	1.21	2.31	0.70	0.13
11-HETE	ME225437	0.28	0.29	0.68	0.76	1.09	0.43	0.89	0.80	0.67	1.47	3.15	1.38	2.21	0.15	0.10
15-HETE	ME225460	0.48	0.48	0.55	1.00	1.16	0.71	1.47	0.85	0.82	1.14	2.44	1.15	1.60	0.73	0.41
15-deoxy PGJ2	ME225441	1.06	0.72	0.55	1.17	0.39	0.87	0.82	0.77	1.19	1.05	1.18	1.49	0.71	0.59	1.07
15-Keto PGE2	ME225439	0.76	1.14	1.61	1.16	0.23	1.58	0.84	0.75	0.92	0.87	1.22	0.65	1.35	0.81	0.80
15-HEPE	ME225465	0.41	0.59	1.47	2.61	0.60	0.46	2.86	0.50	0.62	0.65	0.36	1.73	1.13	0.68	1.24
5-HEPE	ME225468	0.36	0.63	1.27	4.26	1.13	0.57	3.07	0.62	0.97	0.12	0.13	0.25	0.29	0.14	0.51
17-HDoHE	ME225469	0.49	0.56	2.26	3.59	0.68	0.58	1.67	0.25	0.59	0.52	0.63	0.87	0.46	0.57	1.37
9-HEPE	ME225467	0.38	0.71	2.60	3.79	1.23	0.46	2.38	0.60	0.83	0.31	0.24	0.37	0.78	0.43	0.78
5-KETE	ME225486	0.91	0.93	0.27	3.06	1.71	0.92	0.70	0.46	1.05	0.64	0.38	0.98	0.31	0.35	0.92
14(15)-EpETrE	ME225478	0.90	0.56	1.57	1.73	4.24	0.81	2.57	1.45	1.78	0.51	0.24	0.39	0.27	0.58	0.45
9-HETE	ME225462	0.95	1.34	1.08	2.21	3.23	0.43	2.79	0.65	0.46	0.79	0.35	1.48	0.89	0.72	0.24
4-HDoHE	ME225471	0.58	0.85	0.51	2.56	3.28	0.69	1.56	0.54	0.84	0.52	0.52	1.14	0.87	1.07	0.91
5-HETE	ME225464	0.78	1.02	1.22	3.13	3.61	0.85	1.57	0.83	1.28	0.30	0.09	0.56	0.54	0.29	0.21
12_13-DiHOME	ME225444	1.10	1.87	2.01	1.20	4.01	2.33	1.55	1.03	2.06	0.08	0.09	0.12	0.12	0.12	0.13
9_10-e-DiHO	ME225443	1.10	1.05	1.93	1.64	1.40	1.25	1.59	1.72	1.39	0.38	0.31	0.42	1.01	0.35	0.45
13-KODE	ME225484	1.00	0.93	2.25	1.21	2.62	2.23	2.62	1.06	1.51	0.33	0.52	0.34	0.59	0.28	0.49
9_10-DiHOME	ME225445	0.89	1.44	2.58	1.47	2.84	1.57	2.42	1.43	1.91	0.11	0.09	0.19	0.50	0.14	0.16
9-KODE	ME225485	0.81	1.61	1.75	2.18	2.12	1.63	2.72	1.25	1.66	0.12	0.15	0.12	0.17	0.11	0.24
13-HODE	ME225456	0.94	1.68	1.70	2.13	2.18	1.87	1.57	0.62	1.44	0.26	0.25	0.38	0.39	0.26	0.33
9-HODE	ME225457	0.93	1.58	1.58	1.95	2.16	1.58	1.90	0.80	1.43	0.31	0.37	0.49	0.55	0.18	0.29
11(12)-EpETrE	ME225479	0.85	0.73	1.14	1.22	1.57	0.69	2.98	1.49	1.93	0.77	0.60	0.72	0.34	0.24	0.29
11_12-DiHETrE	ME225450	0.64	0.67	3.39	2.23	1.78	0.81	2.64	1.41	1.69	0.35	0.30	0.29	0.26	0.33	0.21
5_6-DiHETrE	ME225452	0.56	0.42	2.43	2.59	2.75	0.75	4.03	1.46	1.71	0.06	0.05	0.05	0.07	0.20	0.07
8-HETE	ME225463	0.50	0.48	2.03	1.91	2.08	0.89	3.48	1.34	1.59	0.51	0.61	0.42	0.35	0.27	0.25
11(12)-EpETE	ME225481	0.64	0.46	1.35	1.58	0.58	0.41	5.24	0.72	1.41	0.62	0.62	0.98	0.73	0.55	0.87
20-HETE	ME225480	0.39	0.28	2.19	1.32	2.05	0.86	5.50	1.41	1.27	0.39	1.10	0.56	0.80	0.69	0.56
9-HOTE	ME225459	0.45	1.08	3.08	3.48	1.41	1.01	3.85	0.52	0.99	0.03	0.03	0.07	0.09	0.19	0.55
12(13)-EpODE	ME225476	0.62	1.27	2.52	2.64	0.87	0.71	4.22	1.06	1.25	0.05	0.05	0.15	0.17	0.07	0.19
9(10)-EpODE	ME225477	0.59	1.34	2.60	2.65	1.30	0.84	4.89	0.93	1.33	0.06	0.08	0.10	0.10	0.17	0.39
12(13)-Ep-9-KODE	ME225483	0.63	1.47	3.58	1.78	1.51	0.49	4.88	1.70	0.97	0.33	0.24	0.37	0.41	0.29	0.30
15(16)-EpODE	ME225475	0.53	1.21	3.64	2.18	2.45	1.30	5.47	0.66	1.38	0.04	0.07	0.09	0.12	0.08	0.20
9_10-DiHODE	ME225448	0.40	0.73	5.61	2.88	1.32	0.68	5.16	0.96	1.20	0.02	0.04	0.07	0.10	0.07	0.24
19_20-DiHDoPE	ME225455	0.24	0.31	4.82	3.39	0.84	0.29	4.68	0.78	0.91	0.24	0.30	0.43	0.45	0.15	0.34
19(20)-EpDPE	ME225482	0.29	0.30	4.02	3.25	1.25	0.31	4.35	0.81	0.99	0.24	0.52	0.45	0.79	0.11	0.13
13-HOTE	ME225458	0.62	1.38	4.01	3.28	1.63	1.13	2.77	0.46	1.17	0.02	0.02	0.04	0.04	0.09	0.21
14_15-DiHETrE	ME225449	0.55	0.57	4.52	2.27	2.36	0.82	3.55	1.26	1.71	0.18	0.17	0.18	0.14	0.24	0.19
15_16-DiHODE	ME225446	0.92	1.08	4.66	2.17	2.79	1.16	3.68	0.72	1.33	0.06	0.09	0.15	0.16	0.13	0.22
12_13-DiHODE	ME225447	0.57	1.00	4.86	2.76	1.78	0.93	4.11	0.71	1.18	0.05	0.07	0.07	0.17	0.10	0.21
8_9-DiHETrE	ME225451	0.42	0.35	4.85	3.28	1.67	0.44	3.79	0.93	1.60	0.09	0.08	0.10	0.10	0.09	0.07

Factors:

F1	Life stage:Adult \| Pregnancy status:Non-pregnant \| Treatment group:Hypoxic \| Sample origin:Arterial
F2	Life stage:Adult \| Pregnancy status:Non-pregnant \| Treatment group:Hypoxic \| Sample origin:Venous
F3	Life stage:Adult \| Pregnancy status:Non-pregnant \| Treatment group:Normoxic \| Sample origin:Arterial
F4	Life stage:Adult \| Pregnancy status:Non-pregnant \| Treatment group:Normoxic \| Sample origin:Venous
F5	Life stage:Adult \| Pregnancy status:Pregnant \| Treatment group:Hypoxic \| Sample origin:Arterial
F6	Life stage:Adult \| Pregnancy status:Pregnant \| Treatment group:Hypoxic \| Sample origin:Venous
F7	Life stage:Adult \| Pregnancy status:Pregnant \| Treatment group:Normoxic \| Sample origin:Venous
F8	Life stage:Adult \| Pregnancy status:Unknown \| Treatment group:Hypoxic \| Sample origin:Arterial
F9	Life stage:Adult \| Pregnancy status:Unknown \| Treatment group:Hypoxic \| Sample origin:Venous
F10	Life stage:Fetus \| Pregnancy status:- \| Treatment group:Hypoxic \| Sample origin:Arterial
F11	Life stage:Fetus \| Pregnancy status:- \| Treatment group:Hypoxic \| Sample origin:Venous
F12	Life stage:Fetus \| Pregnancy status:- \| Treatment group:Normoxic \| Sample origin:Arterial
F13	Life stage:Fetus \| Pregnancy status:- \| Treatment group:Normoxic \| Sample origin:Venous
F14	Life stage:Newborn \| Pregnancy status:- \| Treatment group:Hypoxic \| Sample origin:Venous
F15	Life stage:Newborn \| Pregnancy status:- \| Treatment group:Normoxic \| Sample origin:Venous

Data matrix